ACKNOWLEDGEMENTS
pms 7540Ccmyk 0/0/0/85rgb 75/79/84hex #4C4F54
pms 165Ccmyk 0/74/94/0rgb 255/103/27hex #FF671B
THE NEW ERAOF APLASTIC ANEMIA
AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
In memory of our friend Bruno RotoliUNDER THE AUSPICES OFAIL – Associazione Italiana contro le Leucemie-Linfomi e Mieloma
GITMO – Gruppo Italiana per il Trapianto di Midollo OsseoSIE – Società Italiana di Ematologia
SIES – Società Italiana di Ematologia Sperimentale
SCIENTIFIC SECRETARIATProf. Regis Peffault de Latour
Head of the French reference center for aplastic anemia and PNH University Paris Diderot
1 avenue Claude Vellefaux 75010 - Paris - France
Prof. Antonio Maria RisitanoHead of BMT Unit
AOU Federico II, Federico II University of Naples
Via Pansini, 5 80131 - Napoli - Italy
ORGANIZING SECRETARIATStudio E.R. Congressi
Via Marconi, 36 40122 - Bologna - ItalyPhone +39 051 4210559
Fax +39 051 4210174 E-mail: [email protected]
www.ercongressi.it
FACULTYAndrea Bacigalupo (Roma - IT) Rodrigo T. Calado (Sao Paulo - BR)Mario Cazzola (Pavia - IT)Giovanni Di Minno (Napoli - IT)Carlo Dufour (Genova - IT)Anita Hill (Leeds - UK)Peter Hillmen (Leeds - UK)Taroh Kinoshita (Osaka - JP) Austin Kulasekararaj (London - UK) John D. Lambris (Philadelphia - US) Franco Locatelli (Roma - IT)Lucio Luzzatto (Dar-es-Salaam - TZ) Jaroslaw P. Maciejewski (Cleveland - US) Luca Malcovati (Pavia - IT)Gaetano Manfredi (Napoli - IT)Petra Muus (London - UK)Shinji Nakao (Kanazawa - JP) Junichi Nishimura (Osaka - JP) Rosario Notaro (Firenze - IT)Esther N. Oliva (Reggio Calabria - IT)Tony Pagliuca (London - UK) Fabrizio Pane (Napoli - IT) Jakob R. Passweg (Basel - CH) Regis Peffault de Latour (Paris - FR) Giovanni Pizzolo (Verona - IT) Antonio M. Risitano (Napoli - IT) Alexander Roth (Essen - DE) Valeria Rotoli (Napoli - IT)Annalisa Ruggeri (Roma - IT)Phillip Scheinberg (Sao Paulo - BR) Carmine Selleri (Salerno - IT)Gerard Sociè (Paris - FR)Guido Trombetti (Napoli - IT) Neal Young (Bethesda - US) Alberto Zanella (Milano - IT)
MEETING VENUECENTRO CONGRESSI FEDERICO II - Aula MagnaVia Partenope, 36 80121 - Napoli - Italy
OFFICIAL LANGUAGEEnglish
REGISTRATION FEEThe online registration for attendees are open.Please fill out the form in all its parts at the following link: https://submeet.app/oner/e/the-new-era-2019/
BADGEAll registered participants, speakers and sponsors will be given a badge which they must wear to be admitted to the scientific sessions.
CERTIFICATE OF ATTENDANCEA certificate will be given to all participants at the end of the meeting.
ITALIAN CME CREDITSAn Italian CME application has been submitted as follows:• Provider Studio ER Congressi SRL: ID 828-246564.• No. 11,2 CME credits for Physicians (disciplines: Hematology, Internal Medicine, Oncology, Pediatrics, Pathological Anatomy, Clinical Pathology) and Biologists.• Educational objective: “linee guida-protocolli-procedure”.
CHANGESParts of the program may be changed without notice.
MAY 16-18, 2019 Centro Congressi Federico II Aula Magna - Via Partenope
NAPOLI
THURSDAY MAY 16
12:00 Welcome reception
13:00 Welcome R. Peffault de Latour, A.M. Risitano
13:30 Opening ceremony G. Di Minno, G. Manfredi, F. Pane, A.M. Risitano, V. Rotoli, G. Trombetti
PATHOPHYSIOLOGY OF AA AND PNH Chairs: G. Di Minno, A.M. Risitano
14:00 Special Lecture: Pathophysiology of Aplastic Anemia and PNH: what we know and what we don’t yet know – L. Luzzatto
15:00 The immune system and telomeres in AA – R. Calado
15:30 PNH: lessons learned from complement inhibition – R. Notaro
16:00 Coffee break
SOMATIC MUTATIONS IN BONE MARROW FAILURE SYNDROMES Chairs: M. Cazzola, G. Pizzolo
16:30 Somatic mutations in AA – A. Kulasekararaj
17:00 Somatic mutations in MDS – L. Malcovati
17:30 Debate: is PNH a myeloid malignancy?
• Yes, and we should think how to eliminate rather than tame PNH – J. Maciejewski
• No – G. Sociè
FRIDAY MAY 17
NON-TRANSPLANT TREATMENT OF AA Chairs: S. Nakao, P. Scheinberg
08:30 Special Lecture: The treatment of AA – N. Young
09:30 Debate: is hATG the only ATG preparation?
• Yes – C. Dufour
• No – A. Bacigalupo
10:30 Coffee break
ELTROMBOPAG: EMERGING DATA IN BMF Chairs: C. Selleri, N. Young
11:00 Eltrombopag in AA: the US experience – P. Scheinberg
11:25 Eltrombopag and IST: the EU experience – R. Peffault de Latour
11:50 Eltrombopag and MDS: is there any room? – E.N. Oliva
12:15 Keynote Lecture: The new era of complement inhibition for PNH – A.M. Risitano
13:00 Lunch
NON-TRANSPLANT TREATMENT OF PNHTerminal complement inhibitors • Chairs: G. Sociè, A. Zanella
14:00 Eculizumab: an update – P. Hillmen
14:25 Anti-C5: ALXN1210 – R. Peffault de Latour
14:50 Anti-C5: SKY59 – J. Nishimura, A. Roth
15:15 Anti-C5: RA101495 – A. Hill
15:40 Anti-C5: coversin – P. Muus
16:05 Coffee break
Proximal complement inhibitors • Chairs: T. Kinoshita, L. Luzzatto
16:30 Anti-C3: APL-2 – A. Hill
17:00 Anti-C3: AMY-101 and other compstatins – J. Lambris
17:30 Anti-Factor D: ACH-4471 – A. Kulasekararaj
18:00 Anti-Factor B: LNP023 – A.M. Risitano
SATURDAY MAY 18
HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AA AND PNH Chairs: J. Passweg, R. Peffault de Latour
08:30 HSCT for pediatric AA – C. Dufour
09:00 HSCT for adults AA – A. Bacigalupo
09:30 HSCT for PNH – G. Sociè
10:00 Coffee break
NOVEL STRATEGIES OF TRANSPLANTATION Chairs: A. Bacigalupo, C. Dufour
10:30 The FCC platform and haplo PT-Cy – T. Pagliuca
11:00 Ab-depleted haplo HSCT – F. Locatelli
11:30 Cord blood transplantation – A. Ruggeri
ROUND TABLE: THE FUTURE TRIALS FOR AA Chairs: R. Calado, R. Peffaut de Latour, A.M. Risitano, P. Scheinberg, N. Young
12:00 Proposals from the SAAWP of the EBMT – R. Peffault de Latour, A.M. Risitano
12:20 Proposals from the South America AA group – R. Calado, P. Scheinberg
12:40 Proposals from the NIH – N. Young
13:00 Closing remarks